MedBridgeNZIs the cost of immunotherapy out of reach?
China’s PD-1 treatments (Toripalimab/Sintilimab) offer 70-85% savings vs. Western prices—often starting at just $1,500/cycle.
As a leading medical concierge provider, MedBridgeNZ facilitates seamless access to Medical Tourism China for oncology patients worldwide.
Expert matching
"Fapiao" insurance claim support
End-to-end logistics
Read our 2026 Cost & Hospital Guide: https://zurl.co/2kZr0
China PD-1 Immunotherapy Cost & Hospital Guide: An Objective Choice
Key Takeaways • Significant Cost Efficiency: The estimated out-of-pocket cost for a single cycle of PD-1 immunotherapy at top-tier public hospitals in China ranges from $1,500 to $3,000 USD, representing a 70% to 85% financial reduction compared to Western healthcare systems. • Ethnic Specificity and Clinical Efficacy: Clinical data indicates that regimens such as Toripalimab and Sintilimab demonstrate meaningful overall survival (OS) improvements in Asian populations with specific genomic profi